Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes

Tenofovir disoproxil fumarate (TDF) has been regarded as the most potent drug for treating patients with chronic hepatitis B (CHB). However recently, viral mutations associated with tenofovir have been reported. Here, we found a CHB patient with suboptimal response after more than 4 years of TDF tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ah Ram, Cho, Ju-Yeon, Kim, Jong Chul, Dezhbord, Mehrangiz, Choo, Soo Yeun, Ahn, Chang Hyun, Kim, Na Yeon, Shin, Jae Jin, Park, Soree, Park, Eun-Sook, Won, Juhee, Kim, Dong-Sik, Lee, Jeong-Hoon, Kim, Kyun-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914950/
https://www.ncbi.nlm.nih.gov/pubmed/33562603
http://dx.doi.org/10.3390/ijms22041606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914950/
https://www.ncbi.nlm.nih.gov/pubmed/33562603
http://dx.doi.org/10.3390/ijms22041606

Ejemplares similares